Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2026-02-23 @ 3:18 PM
Study NCT ID:
NCT00648102
Status:
COMPLETED
Last Update Posted:
2010-07-26
First Post:
2008-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer
Sponsor:
Celldex Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CDX1307-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
National Institute of Health, Celldex Therapeutics
Old Organization:
Celldex Therapeutics